The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
Megumi OshimaMin JunToshiaki OhkumaTadashi ToyamaTakashi WadaMark E CooperSamy HadjadjPavel HametStephen HarrapGiuseppe ManciaMichel MarreBryan WilliamsJohn ChalmersMark WoodwardVlado Perkovicnull nullPublished in: Diabetologia (2019)
ClinicalTrials.gov registration no. NCT00145925 and no. NCT00949286.